BDRX vs HCTI

Comparison between Biodexa Pharmaceuticals Plc (BDRX, Company) and Healthcare Triangle Inc (HCTI, Company).

Both BDRX and HCTI are from the Healthcare sector.

5-Year PerformanceBDRX has outperformed HCTI, delivering a return of -92.6% compared to -92.9%

BDRX vs HCTI - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BDRX(COMPANY)	HCTI(COMPANY)
Market Cap	$4.01M	$4.04M
Max Drawdown	100.00%	100.00%
Sharpe Ratio	-0.67	-1.91
5Y Beta	0.00	0.00
Industry	Biotechnology	Health Information Services
P/E Ratio	N/A	-0.03
Debt to Equity	0.53%	16.07%
P/S Ratio	0.58	N/A
P/B Ratio	0.15	N/A

Market Cap

BDRX

$4.01M

Winner

HCTI

$4.04M

Max Drawdown

BDRX

100.00%

Winner

HCTI

100.00%

Sharpe Ratio

Winner

BDRX

-0.67

HCTI

-1.91

5Y Beta

BDRX

0.00

HCTI

0.00

Industry

BDRX

Biotechnology

HCTI

Health Information Services

P/E Ratio

BDRX

N/A

HCTI

-0.03

Debt to Equity

Winner

BDRX

0.53%

HCTI

16.07%

P/S Ratio

BDRX

0.58

HCTI

N/A

P/B Ratio

BDRX

0.15

HCTI

N/A

BDRX vs HCTI - Historical Returns

Returns include dividend reinvestment.

Period	BDRX	HCTI
1 month	-2.86%	-1.35%
3 months	-20.54%	-22.89%
6 months	-85.25%	-98.10%
1 year	-94.06%	-99.45%
5 years(CAGR)	-92.64%	-92.95%
10 years(CAGR)	-82.05%	N/A
Max(CAGR)	-81.75%	-92.95%

BDRX

-2.86%

Winner

HCTI

-1.35%

Winner

BDRX

-20.54%

HCTI

-22.89%

Winner

BDRX

-85.25%

HCTI

-98.10%

Winner

BDRX

-94.06%

HCTI

-99.45%

5Y(CAGR)

Winner

BDRX

-92.64%

HCTI

-92.95%

10Y(CAGR)

BDRX

-82.05%

HCTI

N/A

Max(CAGR)

Winner

BDRX

-81.75%

HCTI

-92.95%

BDRX vs HCTI - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	BDRX	HCTI
2026	-75.12%	-94.02%
2025	-94.45%	-99.71%
2024	-93.98%	-65.45%
2023	-96.47%	+45.47%
2022	-82.72%	-90.23%
2021	-47.50%	-49.58%
2020	-47.98%	N/A
2019	-63.64%	N/A
2018	-89.46%	N/A
2017	-70.49%	N/A
2016	-43.79%	N/A
2015	-34.01%	N/A